Home » Newsletters » BioWorld Science

BioWorld Science

June 9, 2020

View Archived Issues

Data published from phase IIa COMBAT trial of BL-8040 plus pembrolizumab and chemotherapy

Healthspan, lifespan affected differently by caloric restriction

Rottapharm Biotech and Takis to co-develop novel DNA-based vaccine against COVID-19

IGM-8444 preclinical data support its clinical development as cancer immunotherapeutic

Stroke protection effects like night and day

Study suggests strategies to overcome cancer drug resistance

Primary endpoint met in phase II study of garadacimab as preventive treatment in HAE

IDE-397 selected as development candidate in IDEAYA's MAT2A synthetic lethality program

FDA accepts IND application for TAS-0953/HM-06

Novel DYNC2H1 gene variants linked to inherited retinal diseases

Preliminary phase I/IIa results for SNK-01 plus pembrolizumab in NSCLC

Momelotinib shows efficacy in RA and RA-induced anemia in preclinical rodent models

First-in-human data presented for BVAC-B in HER2-positive advanced gastric cancer

Teneobio develops novel bispecific T-cell redirecting antibody targeting CD3 and FRalpha

Jiangsu Chia Tai Tianqing Pharmaceutical divulges HBV antivirals

Inflazome patents NLRP3 inhibitors

Nanjing Sanhome Pharmaceutical synthesizes new TGFR-1 inhibitors

Shanghai De Novo Pharmatech identifies ATR kinase inhibitors

Positive topline data presented from two phase I studies of VE-202

Beijing Scitech-Mq Pharmaceuticals patents new compounds for cancer

Pigv341E mice mimic glycosylphosphatidylinositol biosynthesis deficiency

Soleno reports topline phase III results for DCCR as treatment of Prader-Willi syndrome

Phase I study of adoptive NK cell therapy in patients with relapsed/refractory AML

Assembly Biosciences initiates enrollment in phase I study of ABI-H3733

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...